Autolomous and BioCentriq have collaborated to digitise and accelerate process development and manufacturing activities for cell therapy. Autolomous’ software platform is designed to materially affect the cell and gene therapy sector. BioCentriq will leverage the autoloMATE platform to streamline its process development operations and enhance client experience. This partnership aims to ultimately accelerate batch delivery, […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!